Overexpressed cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors - Cai, Z; Wang, J; Li, Y (Sci China Life Sci, 2023)